• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/68

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

68 Cards in this Set

  • Front
  • Back
Primary Location of Megakaryotes in Bone Marrow
Close to sinus endothelial cells to expel platets directly into sinuses; platelets are fragments of the cytoplasm of megakaryocytes
Function of Glycoproteoin Ib (GPIb)
Platelet receptor for vWF; noncovalently associated with GP IX; complex is called GPIb/IX
Function of Glycoprotein IIb/IIIa
Major plasma membrane receptor for fibrnogen; hidden in resting platelets and has a low affinity for fibrinogen; when platelet is activated GpIIb/IIIa is converted to a high affinity binding form
Structural Zone
Comprised of microtubules + filaments/microfiliaments

Function is to mediate shape change when the platelet is activated
Organelle Zone
Contains granules filled with proteins for platelet function
Alpha and Dense Granules
Alpha: contain platelet growth factors
Dense: Serotonin for vasoconstriction
Platelet derived agonists
ADP, serotonin, platelet activating factor, thromboxane A2
Nonplatelet derived agonists
Collagen, thrombin, epinephrine
How do platelets change in shape once activated?
Discoid shape -> one with long projections emanating from the surface
Thrombosis
Pathologic counterpart of hemostasis; formation of blood clot within intact vessels
Primary Hemostasis
Platelets interact with injured blood vessel and one another to form a hemostatic plug; plug arrests bleeding but can be easily dislodged
Secondary Hemostasis
Coagulations factors recruit fibrin -> strands deposited on the platelet plug stabilizing it
Fibrinolysis
Dissolution of the clot
Fibrinolysis
Dissolution of the clot
Arteriolar Vasoconstriction
Transient event; cant main hemostasis
Platelet Adherence and Activation
Endothelial injury exposes extracellular matrix; platelet activation and adherence; platelets increase their surface area by changing shape; platelets release secondary granules which recruit additional platelets = formation o fplug
Exposure of Tissue Factor
Tissue factor + VII = invivo coagulation; formation of thrombin which creates fibrin meshwork
Secondary Hemostasis
Reinforces initial platelet plug
Antiplatelet and Antithrombotic Endothelial Properties
Protein S also produced by endothelium; cofactor for Protein C
t-PA
Protease that converts plasminogen into plasmin; plasmin cleaves fibrin
Formatoin of Vascular Plug
Glanzman Thrombasthenia; Bleeding disorder due to GP IIb/IIIa deficiency
There are many blood coagulation proteins that need vitaminK
Vit K needed for gamma carboxylation of glutamic acid residues; otherwise factors cant bind to the negatively charged phospholipid surfaces by way of calcium bridges
X->Xa via extrinsic pathway
The above illustration shows the conversion of factor X to factor Xa by way of the extrinsic pathway. Note that calcium ions hold the components together and are essential for the reaction. The activated factor Xa becomes the proteases for the following complex.
Extrinsic vs Intrinsic cascade
Extrinsic vs Intrinsic cascade
Note common pathway
Extrinsic and intrinsic pathways converge at common pathway
Factor X (K dependent); Xa activates prothrombin to thrombin
Function of Thrombin
Procoagulant, antithrombotic, roles in inflammation, roles in cellular proliferation
PA converts Plasminogen to plasmin; plasminogen binds fibrin and degrades it
tPA
Plasminogen + tPA -> Plasmin -> cleavage of fibrin mesh
Thrombin Activatable Fibronolysis Inhibitor
TFAI activated by thrombin/thrombomodulin complex; protects fibrin clot from lysis by inhibiting plasminogen
Alpha 2 Antiplasmin
Binds free plasmin to prevent fibrinolysis; however if plasmin is already bound to fibrin it's protected since its activation site is occupied
Anti-coagulatoin
Antithrombin inactivates factors II, VII, IX, X, and XI; ultimately inactivates thrombin

Herparin accelerates inhibition of target proteases; vascualr endothelium has 'heparin like' molecules
Thrombomodulin
Alters the activity of thrombin from procoagulant to anticoagulant
Protein C (requires protein S)
Activated protein C inhibits factor Va and VIIIa
Tissue Factor Pathway Inhibitor
TFPT binds and inhibits active site on Xa; this complex then reacts with VIIa in complex with tissue factor; inactivation of both proteases
Thrombosis
Due to endothelial injury, stasis or turbulent blood flow or hypercoagulability of blood = Vichow's Triad
Venous Thrombi
Initiated at sites of stasis
Note thrombi in the left and right ventircular apices; they are overlying white fibrous scar tissue
Mural Thrombi in Heart Chambers
This is a laminated thrombus in a dilated abdominal aortic aneurysm
Mural Thrombi in Aortic Lumen
Lines of Zhan
alternating pale pink bands of platelets with fibrin and red bands of red blood cells.
Thrombosed artery. The lumen is delineated by the internal elastic lamina (arrows). The lumen is filled with organized thrombus. The white spaces represent recanalized endothelium lined channels.
Superficial Venous Thrombi
Superficial venous thrombi
Generally occur in saphenous veins in the setting of varicosities
May cause local swelling, congestion, pain, and tenderness
Edema and impaired venous drainage predispose the skin to infections and varicose ulcers
Rarely embolize
Postmortem Clots
Gelatinous consistency with bottom portion being dark red from settling of red cells and the top portion being yellow
Primary or secondary?
Primary Hemostatic Defect
Primary or secondary defect?
Primary Defect
Primary or secondary defect?
Secondary; bleeding in joints
Secondary Hemostatic Defect
Bleeding in joints (hemarthroses) or deep tissues.
Delayed bleeding after injury.
Usually indicates clotting factor deficiency or clotting factor inhibitor.
Primary Hemostatic Defect
Skin or mucosal bleeding.
Bleeding immediately after injury.
Usually suggests numerical or functional abnormalities of platelets or von Willebrand disease.
Primary or Secondary?
Secondary; deep bleed
Forms platelets in BM
Forms platelets in BM
Characteristics of platelets
Cricualte for 7-10 days; removed by reticuloendothelial system third of the platelet pool is in the spleen
Ib-IX
Platelet receptor to adhere to endothelial surface
IIb-IIIa
Platelet-Platelet interaction
Granules
Procoagulin factors inside them; contents released when paltelets get activated
Pseudothrombocytopenia; platelets clot and result in low platelet count
Any splenomegaly condition will produce what
Thrombocytopenia due to destruction of platelets
B12 deficiency; folate deficiency; myelodysplasia
Acute leukemia; myelodysplasia; chronic leukemia
Disseminated Intravascular Coagulation
Excessive activation of coagulation system; thrombi formation in microcirculation; PT and PTT prolonged
Thrombotic thromboytopenic Purpura; deficiency of von willebrand cleaving enzyme; coaglation factors not consumed but platelet plug keeps growing so = thrombocytopeina
Chronic Immune thrombocytopenic purpura
Adults; detected by routine CBC; diagnosis of exclusoin, no splenomegaly

IgG Ab against paltelet glycoproteins; thrombocytopenia due to platelet removal by reticuloendothelial system
Acute Immune thrombocytopenic purpura
IgG Ab against paltelet glycoproteins; thrombocytopenia due to platelet removal by reticuloendothelial system

Seen in children following petechae + viral illness (chills, sore throat, etc)
Bernard-Soulier Syndrome
Deficiency of 1b-IX
Glanzman's Thrombasthenia
Deficiency of Ib-IIIa; can't form plug
von Willebrand Factor
Bridge between platelets and vessel wall; carrier molecule for factor VIII (so deficiency of vWF may lead to deficiency of VIII)
Clotting Cascade
note intrinsic vs extrinsic factor both contribute to common pathway
Mixing Study can tell you whether you're dealing with a factor deficiency or inhibitor
Palpale Purpura; immune complex deposition disease